Article: Breaking Pathologic Signaling in Myeloproliferative Neoplasms: Beyond JAK2 Inhibitors

€2.42

SKU: product-article-19463 Category: General

Description

Description

Breaking Pathologic Signaling in Myeloproliferative Neoplasms: Beyond JAK2 Inhibitors

Top

Article: Breaking Pathologic Signaling in Myeloproliferative Neoplasms: Beyond JAK2 Inhibitors

Description

Related products

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

1 year access Online Belgian Journal of Hematology (BJH)

Article: Highlights in breast cancer

Article: INTRODUCTION